IL87339A0 - 2-((4-piperidyl)methyl)-1,2,3-4-tetrahydroisoquinoline derivatives,their preparation and their application in therapy - Google Patents

2-((4-piperidyl)methyl)-1,2,3-4-tetrahydroisoquinoline derivatives,their preparation and their application in therapy

Info

Publication number
IL87339A0
IL87339A0 IL87339A IL8733988A IL87339A0 IL 87339 A0 IL87339 A0 IL 87339A0 IL 87339 A IL87339 A IL 87339A IL 8733988 A IL8733988 A IL 8733988A IL 87339 A0 IL87339 A0 IL 87339A0
Authority
IL
Israel
Prior art keywords
piperidyl
therapy
methyl
preparation
application
Prior art date
Application number
IL87339A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8711288A external-priority patent/FR2619110B1/fr
Priority claimed from FR8718342A external-priority patent/FR2625504B2/fr
Priority claimed from FR8805129A external-priority patent/FR2630113B2/fr
Priority claimed from FR8805130A external-priority patent/FR2630114B2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL87339A0 publication Critical patent/IL87339A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL87339A 1987-08-07 1988-08-04 2-((4-piperidyl)methyl)-1,2,3-4-tetrahydroisoquinoline derivatives,their preparation and their application in therapy IL87339A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8711288A FR2619110B1 (fr) 1987-08-07 1987-08-07 Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR8718342A FR2625504B2 (fr) 1987-08-07 1987-12-30 Derives de ((benzoyl-1 piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR8805129A FR2630113B2 (fr) 1987-08-07 1988-04-19 Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR8805130A FR2630114B2 (fr) 1987-08-07 1988-04-19 Derives de (piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
IL87339A0 true IL87339A0 (en) 1989-01-31

Family

ID=27446582

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87339A IL87339A0 (en) 1987-08-07 1988-08-04 2-((4-piperidyl)methyl)-1,2,3-4-tetrahydroisoquinoline derivatives,their preparation and their application in therapy

Country Status (10)

Country Link
US (2) US4885302A (da)
EP (1) EP0306375A1 (da)
JP (1) JPH01100167A (da)
KR (1) KR890003733A (da)
AU (1) AU598149B2 (da)
DK (1) DK437588A (da)
FI (1) FI883667A7 (da)
IL (1) IL87339A0 (da)
NO (1) NO883485L (da)
NZ (1) NZ225708A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
US4963563A (en) * 1989-10-13 1990-10-16 Abbott Laboratories 6-substituted-1,2,3,4-tetrahydroisoquinolines
FR2661178B1 (fr) * 1990-04-24 1993-03-12 Synthelabo Derives de [(tetrahydro-1,2,3,4 isoquinoleinyl-2)methyl]-4 piperidinecarboxylates-1 d'alkyle, leur preparation et leur application en therapeutique.
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
FR2747386B1 (fr) * 1996-04-12 1998-05-15 Synthelabo Derives de 3-[(1,2,3,4-tetrahydroisoquinolein-2-yl)methyl] -8-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique
EP0912550A1 (en) * 1996-06-25 1999-05-06 Smithkline Beecham Plc Sulfonamide derivatives as 5ht7 receptor antagonists
US5912342A (en) * 1997-08-12 1999-06-15 Heinonen; Petri Compounds a containing a solid support
AUPP891299A0 (en) * 1999-02-26 1999-03-25 Fujisawa Pharmaceutical Co., Ltd. New 6-membered cyclic compounds
US6664293B2 (en) 1999-02-26 2003-12-16 Fujiwawa Pharmaceutical Co., Ltd. Amide compounds for the potentiation of cholinergic activity
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
US20100331298A1 (en) * 2007-12-10 2010-12-30 Cytopathfinder, Inc. Carboxamide Compounds and Their Use
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
NZ597219A (en) 2009-06-26 2013-05-31 Sanofi Sa Novel fumarate salts of a histamine h3 receptor antagonist
IL305072A (en) * 2021-02-12 2023-10-01 Recovery Therapeutics Inc Compounds, compositions, and methods for modulating fgf activity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2922786A (en) * 1956-12-12 1960-01-26 Bristol Myers Co Therapeutic compounds
DE1670041A1 (de) * 1967-03-14 1972-03-02 American Home Prod Isoindole und Isoindoline
FR7607M (da) * 1968-04-25 1970-01-19
GB1250719A (da) * 1969-03-19 1971-10-20
FR2426046A1 (fr) * 1978-05-18 1979-12-14 Synthelabo Derive de tetrahydro-isoquinoleine, sa preparation et son application en therapeutique
US4495354A (en) * 1982-03-29 1985-01-22 Hoffmann-La Roche Inc. Process for bicyclic diketones
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics

Also Published As

Publication number Publication date
EP0306375A1 (fr) 1989-03-08
FI883667A7 (fi) 1989-02-08
AU598149B2 (en) 1990-06-14
US4885302A (en) 1989-12-05
NO883485D0 (no) 1988-08-05
JPH01100167A (ja) 1989-04-18
DK437588A (da) 1989-03-28
AU2047588A (en) 1989-02-09
FI883667A0 (fi) 1988-08-05
NO883485L (no) 1989-02-08
US4945096A (en) 1990-07-31
KR890003733A (ko) 1989-04-17
NZ225708A (en) 1990-04-26
DK437588D0 (da) 1988-08-05

Similar Documents

Publication Publication Date Title
IL88182A0 (en) Derivatives of 1-desoxynojirimicyin and 1-desoxymannonojirimycin,their preparation and their use in medicaments
NZ239476A (en) 3-amidopyrazole derivatives; medicaments and preparation thereof
EP0412798A3 (en) Substituted pyridines, their preparation, formulations and use in dementia
GR3017062T3 (en) Piperidine compounds and their preparation and use.
NZ234679A (en) 4-phosphonomethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane n-oxide and salts thereof
EP0237073A3 (en) Il-1alpha derivatives and drugs
GB2213482B (en) Isoquinoline derivatives,their preparation and their use
AU2047588A (en) 2-((4-piperidyl)methyl)-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their application in therapy
ZA896205B (en) Annelated tetrahydropyridine acetic acid derivatives,the preparation and use thereof
IL87089A0 (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
DK473289D0 (da) 2'-halogenmethyliden-, 2'-ethenyliden- og 2'-ethynyl-adenosin-derivater, deres fremstilling og anvendelse
IL107133A0 (en) Piperidine derivatives,their preparation and their application in therapy
ZA895271B (en) ((4-piperidyl)methyl)-2,3-dihydro-1h-isoindole and-2,3,4,5-tetrahydro-1h-benzazepine derivatives,their preparation and their application in therapy
ZA888234B (en) New fluoromethoxyphenyl dihydropyridines,processes for the preparation and their use in medicaments
NZ225303A (en) 2,5 dialkyl-3-phenyl piperidine derivatives and pharmaceutical compositions
FI883483A7 (fi) Piperidiinijohdannaiset, niiden valmistus ja käyttö terapiassa
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
IL85944A0 (en) 5-pyrazinyl-1,3,4-oxadiazole and thia-diazole derivatives their preparation and their use as nematicides
NZ226054A (en) N-(substituted alkylidene)-1,2,3,4-tetrahydro-9- acridinamine derivatives and pharmaceutical compositions thereof
IL90000A0 (en) Benzothiazepin-4-one derivatives,their preparation and their application in therapy
IL90909A0 (en) ((4-piperidyl)methyl)-2.3-dihydro-1h-isoindole and-2.3.4.5.-tetrahydro-1h-benzazepine derivatives their preparation and their application in therapy
EP0238357A3 (en) 1,2,4-triazinone derivatives, their preparation and use
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use